Skip to content

Study on the dose effect relationship of Yizhichan in the treatment of cervical and shoulder myofascial pain syndrome

Study on the dose effect relationship of Yizhichan in the treatment of cervical and shoulder myofascial pain syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001220
Enrollment
Unknown
Registered
2025-06-19
Start date
2025-03-26
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain syndrome

Interventions

Treatment duration screening group:Yizhichan(Each patient was treated for a total of 5 minutes. Based on the observation indicators at 1 minute, 2 minutes, 3 minutes, 4 minutes, and 5 minutes of treat
Optimal treatment duration selection group 1:Yizhichan(72 new patients were enrolled, and the treatment duration was one of the optimal treatment durations selected by the "Treatment Duration Screenin
Optimal treatment duration selection group 2:Yizhichan(72 new patients were enrolled, and the treatment duration was another optimal treatment duration selected by the "Treatment Duration Screening Gr

Sponsors

Yueyang Clinical Medical School Shanghai University of Traditional Chinese Medicine Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meets MPS diagnostic criteria; (2) The patient's neck trapezius muscle can touch one or more myofascial trigger points; (3) Capable of walking independently (without the use of auxiliary tools); (4) Age = 18 years old and = 80 years old gender not limited; (5) Body mass index (BMI) = 18.5kg/m2 and = 24 kg/m2; (6) VAS score = 3 points and = 7 points; (7) Those who understand and agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals with a history of neck trauma and surgery (2) Patients with tumors tuberculosis and other diseases in the neck (3) Psoriasis syphilitic neuropathy brown yellow disease metabolic bone disease etc (4) Patients with impaired brain function (5) Severe liver and kidney dysfunction severe cardiovascular disease diabetes and mental disease (6) Individuals who have participated or are currently participating in other clinical trials within the month prior to participating in this study

Design outcomes

Primary

MeasureTime frame
visual analogue scale;short-form of McGill pain questionnaire;

Secondary

MeasureTime frame
Positive and Negative Affect Schedule;Classification and Quantitative Scoring Table for Neck Symptoms and Signs;Young's modulus;Pressure pain threshold;Cervical range of motion;

Countries

China

Contacts

Public ContactSun Wuquan

Yueyang Clinical Medical School Shanghai University of Traditional Chinese Medicine Shanghai

drsunwuquan@126.com18930565609

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026